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Cadmium (Cd) has been found as an environmental pollutant in Mae Sot district, Tak province, Thailand. Prolong
exposure to high levels of Cd of the resident increases high risk of Cd toxicity especially to kidney which is the
primary target of Cd. In order to investigate the early effect of Cd induced renal dysfunction, a kidney injury
molecule-1 (KIM-1), a novel biomarker of renal tubular dysfunction, was measured using an enzyme linked
immunosorbent assay (ELISA). The method was validated and used to quantify the KIM-1 concentrations in the
urine of 700 subjects (260 men, 440 women) who lived in the Cd contaminated area. The KIM-1 concentrations
were compared to the concentrations of two conventional renal tubular dysfunction biomarkers, N-acetyl-β-D-
glucosaminidase (NAG) and β2-microglobulin (β2-MG). Urinary KIM-1 was correlated with urinary and blood Cd as
well as NAG. After adjustment of age and smoking, urinary KIM-1 was correlated with blood Cd more than urinary
NAG did. Clear dose response relationships of urinary KIM-1 with urinary Cd were shown in both men and women.
These results indicate that the urinary KIM-1 might be more sensitive biomarker than urinary NAG and β2-MG for an
early detection of renal tubular dysfunction. It is useful as a tool to detect renal effect of toxicity due to chronic Cd
exposure at high level.
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KIM-1 is a type 1 cell membrane glycoprotein containing
six-cysteine immunoglobulin-like and mucin domains
(Ichimura et al. 1998). It has been reported as an un-
detectable biomarker in normal urine but after kidney in-
jury is expressed at high levels (Ichimura et al. 2004;
Vaidya et al. 2008; Ferguson et al. 2008). Elevated KIM-1
level was also found in human renal diseases associated
with renal fibrosis, inflammation and dysfunction (van
Timmeren et al. 2007). It was proposed as an early indi-
cator of acute kidney injury over the conventional bio-
marker such as blood urea nitrogen, serum creatinine
(Cr), urinary albumin, low molecular weight excreted* Correspondence: ni-koei@kanazawa-med.ac.jp
5Department of Public Health, Kanazawa Medical University, Uchinada,
Ishikawa, Japan
Full list of author information is available at the end of the article
© 2013 Ruangyuttikarn et al.; licensee Springer
Commons Attribution License (http://creativeco
reproduction in any medium, provided the origproteins (α1- and β2-microglobulins (MG)) and tubular
enzymes N-acetyl-β-D-glucosaminidase (NAG) (Han et al.
2002; Vaidya et al. 2006, Bonventre 2009, Hoffmann et al.
2010). It was also proposed as a novel urinary biomarker
of cadmium induced nephrotoxicity via experimented rats
and suggested that it could be indicated as a renal bio-
marker that is more sensitive and accurate than the other
biomarkers (Vaidya et al. 2006; Prozialect et al. 2009).
However, there is very limited report of KIM-1 study in
human population exposed to cadmium (Cd) except the
study of association between KIM-1 and urinary Cd in eld-
erly with low-dose Cd exposure (Pennemans et al. 2011).
Cd is an important industrial and environmental pol-
lutant that adversely affects multiple organ systems
(WHO 1992; Jarup et al. 1998), of which the kidney is
the primary target in humans with chronic Cd exposure
(Friberg 1984; Lauwerys et al. 1984; Jarup et al. 1998).. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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malacia and osteoporosis with the resultant multiple
bone fractures are predominant clinical signs of the Itai-
itai disease. Itai-itai disease was the most severe mani-
festation of cadmium toxicity in patients documented in
Japan who suffered chronic exposure to high cadmium
concentrations in contaminated water and rice (Nogawa
et al. 1987; Aoshima et al. 1988).
In Thailand, elevated levels of Cd in paddy soils and rice
grain downstream of a zinc mineralized area in Mae Sot
district, Tak province was reported in 2005 (Simmons et al.
2005). The Mae Sot district is located in a mountainous
area on the Thai–Myanmar border, and it was famous for
excellent rice that won national awards for many years. The
contamination of Cd in rice is associated with suspended
sediment transported to fields via the irrigation supply.
Over 90% of the rice grain samples collected contained Cd
at concentrations exceeding the Codex Committee on Food
Additives and Contaminants (CCFAC) draft Maximum
Permissible Level for rice grain of 0.2 mg/kg. This poses a
significant public health risk to local communities.
Prolonged consumption of the contaminated rice is
believed to be a major source of Cd accumulation in the
Mae Sot district residents. Our recent studies demon-
strated that Mae Sot people have high risk of kidney
damage with significantly high urinary Cd and high
levels of renal dysfunction biomarkers such as α1- and
β2-microglobulins (α1-MG, β2-MG) and N-acetyl-β-D-
glucosaminidase (NAG) (Swaddiwudhipong et al. 2007;
Teeyakasem et al. 2007; Honda et al. 2010). The residents
also have high levels of Cd-associated chronic diseases
such as hypertension, diabetes, osteoporosis and anemia
(Swaddiwudhipong et al. 2010; Nambunmee et al. 2010,
2011). Swaddiwudhipong et al. (2012) recently reported
a five year study (2005–2010) of the residents with
prolonged exposure to high levels of environmental Cd,
showing toxic effects may persist long after Cd expos-
ure is reduced.
Therefore, a sensitive, specific and economical method
for early detection of renal dysfunction induced by Cd is
needed for health monitoring of the population, in
whom signs and symptoms of acute kidney injury may
not yet be manifested. We report here a use of the KIM-1
as a sensitive biomarker for early detection of renal tubu-
lar dysfunction in Mae Sot residents with high Cd expos-
ure and compared its prevalence with those of two
conventional renal biomarkers, NAG and β2-MG concen-
trations to show usefulness of KIM-1 measurement
among Cd exposed population at high level.
Materials and methods
Study population
Seven hundred residents permanently living in the Cd
contaminated area in 12 villages in Mae Sot district,were recruited to this study. They were comprised of 260
men and 440 women aged between 21–89 years. They
had been selected non-randomly from among those found
in a 2004–2005 survey (Swaddiwudhipong et al. 2007)
with high urinary Cd levels greater than 5 μg/g Cr. All sub-
jects were advised of the aim and methods of the project
and consented to provide morning urine sample, 5–10 ml
of venipuncture blood, and demographic and health infor-
mation. The study was approved by the Research Ethics
Committee of the Faculty of Medicine, Chiang Mai
University (Protocol approval No. 010/2009).
Collection of urine and blood samples
The morning urine samples were collected in a poly-
ethylene bottle after the subjects underwent physical
examination and anthropometric measurements. Qua-
litative tests for pH, protein, glucose, occult blood,
urobilinogen and ketone body were conducted on urine
samples at the sampling site using paper strips (Ames
test, Bayer, Germany). Each urine sample was divided
into three aliquots of which any with pH < 5 one aliquot
was adjusted to the pH 6–8 by 0.5N sodium hydroxide
to prevent degradation of β2-MG in acidic urine. Venous
blood was collected from each subject in an EDTA
vacutainer. All samples were kept at −20°C before
analysis.
Determination of blood Cd and urinary Cd and creatinine
Blood and urinary Cd concentrations were quantified
using a flameless atomic-absorption spectrometer (Shimadzu
Model AAS-6300, Japan). The urine was diluted by 20 mg/l
palladium chloride solution in 5%HNO3 as a matrix modi-
fier at the ratio of 1:1. Proteins in blood were precipitated
by 5%HNO3 at the ratio of 1:2 (Honda 2010). Method val-
idation of the technique were performed and verified by
certified standard reference materials [urine reference
material Lot No. 2670 (National Bureau of Standards,
Washington D.C.) and control blood Lot No. 620302
(Behring Institute, Dresden, Germany)], to ascertain the
accuracy and precision of the method. Detection limits of
urinary and blood Cd were 0.06 μg/g Cr and 0.2 μg/l, re-
spectively. The urinary Cd concentrations of each subjects
were adjusted by each urinary creatinine concentrations
measured by the enzyme assay (Cica liquid–S, Kantokagaku
Reagent Division, Ltd., Japan).
Determination of urinary renal markers
The NAG level was quantified by a colorimetric assay
using an NAG test kit (Shionogi Pharmaceuticals, Japan).
The β2-MG level was quantified by an enzyme immuno-
assay (GLAZYME β2-microglobulin-EIA test kit, Sanyo
Chemical Industries Ltd., Japan). Concentrations of both
urinary NAG and β2-MG were also adjusted per g Cr.
Table 1 Characteristics of the subjects and concentrations
of cadmium and renal markers
Variables Men Women Total
(N = 260) (N = 440) (N = 700)
Age (years) 55.6 ± 14.0 53.1 ± 12.7 54.0 ± 13.2
Weight (kg) 54.7 ± 10.0 51.3 ± 10.6 52.6 ± 10.5
Height (cm) 160.7 ± 5.9 151.1 ± 5.1 154.6 ± 7.1
BMI (kg/m2) 21.1 ± 3.1 22.5 ± 4.2 22.0 ± 3.1
Duration of residence (years) 54.1 ± 15.0 52.5 ± 13.3 53.1 ± 14.0
Never smoked (N) 16 (6.2%) 216 (49.1%) 232 (33.1%)
Ex-smokers (N) 86 (33.1%) 118 (26.8%) 204 (29.1%)
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linked immunoassay (ELISA) using human KIM-1 standard,
mouse anti-human KIM-1 antibody and horse radish per-
oxidase conjugated mouse anti-human KIM-1 antibody
which were purchased from R&D system, Minneapolis,
MN, USA. The technique of ELIZA development was vali-
dated according to a bioanalytical recommendation (FDA
2001; DeSilva et al. 2003). The detection limit of urinary
KIM-1 was 32.2 pg/ml and the limit of quantification was
110.7 pg/ml. The detail process of preparation and val-
idation of our KIM-1 assay was reported in somewhere
(Panyamoon et al. 2009).Occasional smokers (N) 19 (7.3%) 20 (4.5%) 39 (5.6%)
Regular smokers (N) 139 (53.4%) 86 (19.6%) 225 (32.2%)
Blood cadmium (μg/L) 6.7 (1.0) 4.9 (2.0) 5.5 (2.0)
Urinary cadmium (μg/gCr) 6.3 (1.8) 7.0 (1.9) 6.7 (1.9)
KIM-1 (pg/gCr) 860 (2.3) 1050 (2.2) 974.8 (2.3)
NAG (U/gCr) 5.3 (1.9) 5.7 (1.9) 5.5 (1.9)
β2-MG (μg/gCr) 367 (9.5) 184 (6.1) 237.9 (7.5)
N: number of subjects; BMI: body mass index; μg/L: microgram per liter;
μg/gCr: microgram per gram creatinine; pg/gCr: picogram per gram
creatinine; U/gCr: unit per gram creatinine; KIM-1: Kidney injury molecule-1;
NAG: N-acetyl-β-D-glucosaminidase; β2-MG: β2−microglobulin; values of
cadmium and renal markers represent geometrical mean (geometrical
standard deviation).Statistical analysis
Data analysis was performed using the SPSS statistical
package (Version 11.5). Logarithmic transformation was
applied to Cd concentrations in urine and blood and all
renal markers to achieve a normal distribution before
being subjected to data analysis. Correlations between
Cd exposure markers and KIM-1 concentrations were
assessed by Spearman’s rho analysis. Partial correlation
analysis between Cd exposure and renal markers were
performed after controlling for age and/or smoking habit
at present. Comparisons of Cd exposure among groups
at different smoking status and levels of renal markers
among groups at different urinary Cd levels were ana-
lyzed by one-way ANOVA. Dose–response relationship
between urinary Cd and KIM-1-uria was analyzed by
probit regression model. At this time, KIM-1-uria was
determined using cut-off value which was the 95 per-
centile values of urinary KIM-1 in the subjects with
urinary Cd < 2 μg/g Cr (defined as non-exposure level of
the urinary Cd by WHO). The P values of 0.05 or less
were considered to identify statistical significance.Results
Characteristics of the subjects and qualitative screening
results
There were no different between genders of the average
age, weight, height, body mass index and duration of
residence in the area of the subjects in this study
(Table 1). The mean age of the subjects was 54 years old
and they all live permanently in the contaminated area
for approximately 53 years (Table 1). Four hundred and
twenty one subjects (61%) out of 700 (159 men and 262
women) were older than 50. Although all subjects had
no severe clinical symptoms, the on-site screening exam-
ination with urinary strips showed 392 people had posi-
tive urinary protein, 326 subjects had positive blood, 2
subjects were found with positive urinary ketone and
glucose and 105 subjects had urinary pH equal to 5 or
lower. In addition, no participants had occupational ex-
posure to Cd.There were 232 subjects (33.1%) who had never smoked
with lower rate found in men (6.2%) than in women
(49.1%) and number of men with regular smoking (53.4%)
were more than the number of regular smoking women
(19.6%) (Table 1). The geometrical means of Cd in both
urine and blood were also shown in Table 1 with no gen-
ders difference. Figure 1 showed scatter plot of blood
Cd and urinary Cd with high correlation between them
(r=0.666, P<0.001).
Exposure markers, smoking status and renal dysfunction
markers
Only blood Cd concentrations in smoking status were
significantly different from those Cd levels in never
smoked subjects in both men and women (Table 2).
There was no age difference of urinary cadmium in both
genders, however, blood Cd in aged group ≥ 50 years
were significantly higher than those levels in the younger
(P < 0.001, data not shown).
Scatter plots between log transformed urinary KIM-1,
NAG and β2-MG and urinary Cd were shown in Figure 2.
All of the renal markers were highly correlated to Cd
exposure (P < 0.001). Then, unadjusted and adjusted
correlations by age and smoking status between blood
Cd and renal markers were performed because of sig-
nificant relationship of blood Cd and smoking status,
and their correlation coefficients were shown in Table 3.
Urinary Cd was analyzed with simple and partial correla-
tions after controlling age in comparison to renal markers
r  =  0.666
p  <  0.001












Figure 1 Positive correlation of the cadmium concentrations in urine (μg Cd/g Cr) and whole blood (μg Cd/L) in the inhabitants
(n=700) living in cadmium polluted area, Mae Sot district, Tak province (Spearman’s rho analysis).
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related with Cd exposure markers after adjusting age
and/or smoking. Particularly, urinary KIM-1 was signifi-
cantly increased (P < 0.001) with increase of blood Cd
compared to the NAG and β2-MG in men after elimin-
ation of influence by age and smoking.
Dose effect and dose response relationships of renal
dysfunction and urinary Cd
When 4 levels of urinary Cd concentrations were classi-
fied, the renal dysfunction biomarkers in this study show
significant positive dose effect relationships with urinary
Cd (Table 4). Moreover, to confirm the dose response re-
lationships between urinary KIM-1 and urinary Cd, pro-
bit regression analysis was performed based on the
prevalence rates of KIM-1-uria shown in Table 5. At this
time, 95 percentile value of the quantified urinary KIM-1
in the subjects in both genders whose urinary Cd < 2 μg/g
Cr was used as cutoff level to determine KIM-1-uria. After
logit-converting prevalence of KIM-1uria, scatter plots
between cadmium (dose) and prevalence rates of KIM-
1-uria (response) were performed and shown in Figure 3,
with probit regression lines of Y = 2.27X - 3.24 for menTable 2 Cadmium exposure and smoking status of the subjec
Smoking status Blood Cd (μg/L)
Men women total
Never smoked (n=232) 4.9 (2.0) 4.4 (2.1)
Ex-smoker (n=204) 6.3 (2.0) 4.8 (2.3)
Occasional smoker (n=39) 7.1 (1.7) 6.8 (1.6)**
Regular smoker (n=225) 7.3 (1.8)* 6.7 (1.6)***
Cd: cadmium; μg/L: microgram per liter; μg/g Cr: microgram per gram creatinine.
*P<0.05; **P<0.01; ***p<0.001 compared to never smoked group.
Values of cadmium represent geometrical mean (geometrical standard).and Y = 2.23X - 3.81 for women. The regression lines dem-
onstrates good fitness of Fit χ2 at 14.6 (P = 0.201) for men
and 9.05 (P = 0.618) for women. When factor of age was
added into the model, regression lines with good fitness
were Y = 1.28X + 0.11Age – 8.56 (χ2 = 7.98, P = 0.631)
for men and Y = 2.19X + 0.013Age – 4.48 (χ2 = 8.95, P =
0.537) for women. The estimated threshold value of the
urinary Cd which caused KIM-1-uria and Cd concentra-
tions corresponded to 10% prevalence of KIM-1-uria for
the subjects aged 55.5 years old, was 1.3 μg/g Cr for men
and 5.2 μg/g Cr for women.
Discussion
Mae Sot district was the first reported case of environ-
mental Cd in Thailand from zinc mining activities. The
Cd contaminated area was estimated to be about 13,200
rais (× 1,600 m2) of paddy field affecting 12 villages with
a total population of 12,075 in 2004 (Data from Tak Pro-
vincial Office). Since the residents consumed local rice
grown daily, they were at high risk of chronic Cd tox-
icity. Health risk assessment and biomarkers monitoring
among residents is important to help protect systemic
toxicity of Cd before reaching severity. Among ourts
Urinary Cd (μg/g Cr)
Men women total
4.4 (2.1) 5.9 (2.3) 7.5 (3.0) 7.3 (3.0)
5.4 (2.2)** 6.5 (2.0) 6.4 (2.0) 6.5 (2.0)
6.9 (1.6)*** 7.8 (1.9) 7.1 (1.7) 7.5 (1.8)
7.0 (1.7)*** 6.1 (1.8) 7.5 (1.6) 6.6 (1.7)
Figure 2 Positive correlations of the urinary cadmium and renal dysfunction biomarkers; A) kidney injury molecule-1 (KIM-1),
B) N-acetyl-β-D-glucosaminidase (NAG) and C) β2−microglobulin (β2-MG), using Spearman’s rho analysis.
Table 4 Dose response relationship of the urinary
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lower than 2 μg/g Cr and 183 subjects (62 men and 121
women) with very high urinary Cd over 10 μg/g Cr, indi-
cating that the exposure is still going on in some sub-
jects and some but less has reduced. One of the subjects
had urinary KIM-1 at the concentration of 15330 pg/g
Cr, suggesting the existence of severe renal tubular in-
jury in Mae Sot residents. This person was later referred
for medical checkup and proper healthcare at Mae Sot
General Hospital.
Blood and urinary Cd are useful indicators of Cd body
burden, whereas blood Cd also reflects Cd exposure dur-
ing recent several years (WHO 1992). Men were found
to have statistically significant higher blood Cd concen-
trations than women (Table 2). The results were differ-
ent from a previous report of Rey et al. (1997) in which
there was no difference between gender and blood Cd
concentration was 0.94 μg/L in men and 1.12 μg/l in
women. Willer (1992) also reported the concentration of
whole blood Cd at 0.19 μg/L. The difference in these
studies might have resulted from either high dietary Cd
exposure or smoking consumption. Since smoking is oneTable 3 Relationships between cadmium exposure
marker and renal dysfunction markers
KIM-1 NAG β2-MG
Men (N = 260)
U-Cd Corr. 0.295 *** 0.320 *** 0.182 **
Partial corr. 0.289 *** 0.312 *** 0.156 *
B-Cd Corr. 0.265 *** 0.200** 0.199 **
Partial corr. 0.224 *** 0.150 * 0.132 *
Women (N = 440)
U-Cd Corr. 0.215 *** 0.251 *** 0.190 ***
Partial corr. 0.205 *** 0.242 *** 0.178 ***
B-Cd Corr. 0.205 *** 0.165 *** 0.228 ***
Partial corr. 0.161 ** 0.103 * 0.174 ***
U-Cd: urinary cadmium; B-Cd: whole blood cadmium; N: number of subjects;
Corr.: correlation coefficient (Pearson); Partial corr.: partial correlation
coefficient after controlling.
by age for U-Cd, by age and smoking habit (yes1, no0).
*p<0.05; **p<0.01; ***p<0.001.of cadmium exposure source, Cd concentrations in blood
and urine with never smoked people showed high Cd
levels over 2 μg/g Cr and blood Cd was increased accord-
ingly to the smoking status (Table 2), however, urinary Cd
concentrations were not different between non-smokers
and smokers. Therefore, correlations of blood Cd with
renal markers were analyzed after adjusting not only age
but also smoking status, but correlations of urinary Cd
was computed after adjusting only age.
The critical concentration of Cd that induced ne-
phropathy has been studied. Because nephropathy was
not a clear-cut clinical entity, many biomarkers for early
detection of Cd induced renal dysfunction such as NAG,
albumin, β2-MG, α1-MG etc. had been used in several stud-
ies (Jung et al. 1993; Jin et al. 2002; Moriguchi et al. 2003;
Teeyakasem et al. 2007). In Thai subjects, Teeyakasem et al.
(2007) used urinary Cd as an index of Cd exposure and
used β2-MG, NAG, total protein, albumin, aminonitrogen,
lysozyme and glucose as indicators of Cd nephrotoxicity.
However, another low molecular weight protein, i.e.cadmium (4 levels) and renal dysfunction biomarkers of
the subjects
Cadmium N KIM-1 NAG β2-MG
(μg/g Cr) (pg/g Cr) (U/g Cr) (μg/g Cr)
Men
< 2 13 513.9 (2.2) 4.0 (2.2) 137.1 (5.0)
2–4.99 67 686.8 (2.2) 4.5 (1.8) 266.2 (9.4)
5–9.99 118 863.2 (2.2)* 5.0 (1.7) 345.0 (8.9)
≥ 10 62 1211.2 (2.1)** 7.5 (2.0)** 721.3 (10.5)*
Women
< 2 23 711.9 (2.0) 3.8 (2.1) 61.4 (3.4)
2–4.99 95 922.4 (2.2) 5.1 (1.8) 175.1 (5.6)*
5–9.99 201 1040.9 (2.2) 5.5 (1.7)* 160.9 (5.9)*
≥ 10 121 1269.4 (2.4)** 7.1 (1.9)*** 294.8 (6.7)***
N: number of subjects; KIM-1: kidney injury molecule-1; NAG: N-acetyl-β-D-
glucosaminidase; β2-MG: β2−microglobulin.
*P<0.05; **P<0.01; ***P<0.001: significant different from the subjects group
with cadmium concentrations below 2 μg/gCr (Dunnet T test for post hock).
Values of renal markers represent geometrical mean (geometrical
standard deviation).











0–0.99 3 1.0 45.0 0 (0.0)
1–1.99 10 1.5 57.0 1 (10.0)
2–2.99 13 2.8 51.0 3 (23.1)
3–3.99 28 3.6 49.0 1 (3.6)
4–4.99 26 4.5 51.5 3 (11.5)
5–5.99 36 5.5 56.0 8 (22.2)
6–6.99 34 6.5 53.0 7 (20.6)
7–7.99 20 7.5 49.0 4 (20.0)
8–8.99 14 8.4 58.0 3 (21.4)
9–9.99 14 9.5 60.0 7 (50.0)
10–14.99 47 11.8 61.0 19 (40.4)
15–19.99 7 15.6 47.0 0 (0.0)
20 – 8 28.4 56.0 4 (50.0)
Women
0–0.99 3 0.8 43.0 0 (0.0)
1–1.99 20 1.6 52.0 1 (5.0)
2–2.99 16 2.5 58.5 2 (12.5)
3–3.99 44 3.5 50.5 2 (4.5)
4–4.99 35 4.6 53.0 4 (11.4)
5–5.99 41 5.5 51.0 3 (7.3)
6–6.99 43 6.6 50.0 8 (18.6)
7–7.99 40 7.3 53.0 5 (12.5)
8–8.99 42 8.5 56.0 7 (16.7)
9–9.99 35 9.4 54.0 3 (8.6)
10–14.99 77 11.7 54.0 11 (14.3)
15–19.99 23 16.5 52.0 7 (30.4)
20 – 21 23.9 55.0 9 (42.9)
N: number of subjects, y: years, U-Cd: urinary Cd.
Cutoff values for U-KIM-1 = 1,577 μg/g Cr for men, 2,413 μg/g Cr for women,
which were 95%tile values of the subjects with U-Cd < 2 μg/g Cr.
Figure 3 Dose–response relationships between log10 transformed
urinary cadmium concentrations (U-Cd) and logit-transformed
prevalence rates of urinary KIM-1 (Logit) in men (open square)
and women (black diamond). Prevalence rates were determined
using cutoff values for urinary KIM-1 at 1,577 and 2,413 μg/g Cr for men
and women, respectively, which were 95 percentile values of urinary
KIM-1 in men and women with urinary Cd < 2 μg/g Cr. Regression line:
Y = 2.27 log X −3.12 for men (broken line), Y = 2.23 X −3.81 for women
(solid line).
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ied in the urine of high Cd exposure such as that in the
Mae Sot inhabitants. The developed in house-ELISA for
quantitating urinary KIM-1 validated in our previous
study (Panyamoon et al. 2009) was highly sensitive, with
LOD of 33.2 pg/mL and LOQ of 110.7 pg/mL. There was
no urinary sample with KIM-1 concentration lower than
the LOQ value. The assay precision in all %CV was less
than 20% and was accepted as very high precision (FDA
2001). The assay accuracy was also high with approxi-
mately 90% recovery. This result indicated that our devel-
oped ELISA technique gave a very high sensitivity and
specificity for KIM-1 measurement in urine samples. In
addition, KIM-1 in urine was stable even after the urine
was frozen and thawed for 4 cycles. The finding was simi-
lar to what Han and Bonventre (2004) reported. KIM-1
was also stable for short-term storage at 4°C for 5 days.
Nowadays, there is limited data of KIM-1. Urinary KIM-1had been mostly used as a biomarker of nephrotoxic in-
jury in animal models (Ichimura et al. 1998; Vaidya et al.
2006; Prozialeck et al. 2009) and only in human patients
with renal diseases (Han et al. 2002). This is the first
report of KIM-1 as a potential marker on indication
of renal dysfunction induced by environmental expos-
ure to cadmium.
Urinary excretion of NAG had been recommended as a
sensitive biomarker of Cd exposure and is more sensitive
than β2-MG (WHO 1992). However, Jung et al. (1993)
recommended a combination of NAG and α1-MG for
early detection of Cd induced renal injury. Fifty eight men
and 123 women in this study had urinary NAG excretion
over 8 U/g Cr suggested proximal tubular damage had oc-
curred. Although the urinary NAG was shown to be the
best biomarker that correlated well with urinary Cd, we
found that the prevalence rate of NAG-uria was lower
than hyper KIM-1-uria. In addition, an increase of NAG
level had been reported in variable of conditions such as
chronic glomerular disease (Bazzi et al. 2002) and diabetic
nephropathy (Ikenaga et al. 1993). The urinary NAG is
quantitated by colorimetric assay technique and its activity
might be inhibited by endogenous urea (Bondiou et al.
1985), while urinary KIM-1 was measured via antigen-
antibody reaction; therefore, KIM-1 might be more sensi-
tive than urinary NAG.
In this study, urinary β2-MG had wide ranges between
5–107,883 μg/g Cr. Two women had β2-MG concentra-
tions over 100,000 μg/g Cr, suggesting severe renal tubu-
lar dysfunction. However, an increase of urinary β2-MG
excretion had been also found in other diseases, cardiac
surgery (Dehne et al. 1995) and renal transplantation
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to be degraded rapidly at room temperature and in the
urine with pH less than 6.0. Thus, it is reasonable to
conclude that urinary KIM-1 is a better biomarker for
indicating renal tubular dysfunction than β2-MG.
In the present study, clear dose–response relationship
between urinary KIM-1 and urinary Cd was shown, and
threshold values of KIM-1-uria in both genders were
lower than those of urinary NAG and β2-MG. These re-
sults also confirm urinary KIM-1 is useful marker to de-
tect urinary tubular dysfunction at early stage. However,
in this analysis, 95 percentile values of KIM-1 of men
and women with urinary Cd < 2 μg/g Cr were used for
cut-off values to calculate of prevalence of KIM-1-uria.
This is a big limitation of this analysis, because we have
no controls and residents with lower exposure needed to
use as controls. In future, we select suitable controls for
Mae Sot residents and measure KIM-1 to detect refer-
ence value for Thai population. Then, we are going to
use this marker to detect early sign of renal effect in Cd
exposed subjects, particularly young people with low Cd
body burden.
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